halothane has been researched along with ono-ae1-329 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ando, K; Cao, X; Honda, A; Izumi-Nakaseko, H; Katagi, J; Nakamura, Y; Nomura, H; Ohara, H; Satoh, Y; Sugiyama, A | 1 |
| Ando, K; Cao, X; Honda, A; Izumi-Nakaseko, H; Katagi, J; Nakamura, Y; Nomura, H; Ohara, H; Sugiyama, A; Wada, T | 1 |
2 other study(ies) available for halothane and ono-ae1-329
| Article | Year |
|---|---|
Cardiohemodynamic and electrophysiological effects of a selective EP4 receptor agonist ONO--AE1--329 in the halothane-anesthetized dogs.
Topics: Action Potentials; Anesthesia, General; Anesthetics, Inhalation; Animals; Blood Pressure; Cardiac Output; Cardiotonic Agents; Cardiovascular System; Dogs; Drug Administration Schedule; Electrocardiography; Electrophysiologic Techniques, Cardiac; Halothane; Heart Conduction System; Heart Rate; Hemodynamics; Infusions, Intravenous; Male; Methyl Ethers; Models, Animal; Myocardial Contraction; Receptors, Prostaglandin E, EP4 Subtype; Signal Transduction; Time Factors; Vascular Resistance; Vasodilation; Ventricular Function, Left; Ventricular Pressure | 2015 |
Effects of a prostagrandin EP4-receptor agonist ONO-AE1-329 on the left ventricular pressure-volume relationship in the halothane-anesthetized dogs.
Topics: Anesthetics, Inhalation; Animals; Blood Pressure; Cardiac Output; Dobutamine; Dogs; Dopamine; Female; Halothane; Heart Rate; Methyl Ethers; Milrinone; Receptors, Prostaglandin E, EP4 Subtype; Stroke Volume; Vascular Resistance; Ventricular Function, Left; Ventricular Pressure | 2016 |